Search Results - Robert M. Wenham

Refine Results
  1. 1
    The Molecular Biology of Endometrial Cancers and the Implications for Pathogenesis, Classification, and Targeted Therapies

    The Molecular Biology of Endometrial Cancers and the Implications for Pathogenesis, Classification, and Targeted Therapies by Nisha Bansal, Vimala Yendluri, Robert M. Wenham

    Published 2009
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Implementing Personalized Medicine in a Cancer Center

    Implementing Personalized Medicine in a Cancer Center by David Fenstermacher, Robert M. Wenham, Dana E. Rollison, William S. Dalton

    Published 2011
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Lagged relationships among sleep disturbance, fatigue, and depressed mood during chemotherapy.

    Lagged relationships among sleep disturbance, fatigue, and depressed mood during chemotherapy. by Heather Jim, Paul B. Jacobsen, Kristin M. Phillips, Robert M. Wenham, William S. Roberts, Brent J. Small

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    New therapies for advanced, recurrent, and metastatic endometrial cancers

    New therapies for advanced, recurrent, and metastatic endometrial cancers by Vicky Makker, Angela K. Green, Robert M. Wenham, David G. Mutch, Brittany A. Davidson, David S. Miller

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    A Phase I Trial of Dasatinib, an Src-Family Kinase Inhibitor, in Combination with Paclitaxel and Carboplatin in Patients with Advanced or Recurrent Ovarian Cancer

    A Phase I Trial of Dasatinib, an Src-Family Kinase Inhibitor, in Combination with Paclitaxel and Carboplatin in Patients with Advanced or Recurrent Ovarian Cancer by Angeles Alvarez Secord, Deanna Teoh, William T. Barry, Miao Yu, Gloria Broadwater, Laura J. Havrilesky, Paula S. Lee, Andrew Berchuck, Johnathan M. Lancaster, Robert M. Wenham

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKT

    Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors conta... by Christopher R. Garrett, Domenico Coppola, Robert M. Wenham, Christopher L. Cubitt, Anthony Neuger, Timothy J. Frost, Richard M. Lush, Daniel M. Sullivan, Jin Q. Cheng, Saı̈d M. Sebti

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    MicroRNA Expression Profiling in Human Ovarian Cancer: <i>miR-214</i> Induces Cell Survival and Cisplatin Resistance by Targeting <i>PTEN</i>

    MicroRNA Expression Profiling in Human Ovarian Cancer: <i>miR-214</i> Induces Cell Survival and Cisplatin Resistance by Targeting <i>PTEN</i> by Hua Yang, William Kong, Lili He, Jianjun Zhao, Joshua D. O’Donnell, Jiawang Wang, Robert M. Wenham, Domenico Coppola, Patricia A. Kruk, Santo V. Nicosia, Jin Q. Cheng

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting p53/Nanog

    MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting p53/Nanog by Cheng‐Xiong Xu, Meng Xu, Lei Tan, Hua Yang, Jennifer Permuth‐Wey, Patricia A. Kruk, Robert M. Wenham, Santo V. Nicosia, Johnathan M. Lancaster, Thomas A. Sellers, Jin Q. Cheng

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer

    Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer by Stephen A. Cannistra, Ursula A. Matulonis, Richard T. Penson, Julie Hambleton, Jakob Dupont, Howard Mackey, Jeffrey A. Douglas, Robert A. Burger, Deborah K. Armstrong, Robert M. Wenham, William P. McGuire

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Using the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated With Adjuvant Radiation Therapy

    Using the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated With Adjuvant Radiation Therapy by Homan Mohammadi, Austin Prince, Nicholas Figura, Jeffrey Peacock, Daniel C. Fernandez, Michael E. Montejo, Hye Sook Chon, Robert M. Wenham, Steven A. Eschrich, Javier F. Torres–Roca, Kamran A. Ahmed

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

    Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer by Siqing Fu, Bradley R. Corr, Kerry Culm-Merdek, Colleen Mockbee, Hagop Youssoufian, Robert Stagg, R. Wendel Naumann, Robert M. Wenham, Rafael D. Rosengarten, Laura E. Benjamin, Erika Hamilton, Kathleen N. Moore

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Ovarian Adenocarcinomas in the Laying Hen and Women Share Similar Alterations in p53, ras, and HER-2/neu

    Ovarian Adenocarcinomas in the Laying Hen and Women Share Similar Alterations in p53, ras, and HER-2/neu by Amy Hakim, Catherine P. Barry, H. John Barnes, Kenneth E. Anderson, James N. Petitte, Regina S. Whitaker, Jonathan Lancaster, Robert M. Wenham, Donna K. Carver, Jane M. Turbov, Andrew Berchuck, Levy Kopelovich, Gustavo C. Rodriguez

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study

    Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study by Erin Bishop, James Java, Kathleen N. Moore, Nick M. Spirtos, Michael L. Pearl, Oliver Zivanovic, David Kushner, Floor Backes, Chad A. Hamilton, Melissa A. Geller, Jean Hurteau, Cara Mathews, Robert M. Wenham, Pedro T. Ramírez, Susan Zweizig, Joan L. Walker

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    BAD-mediated apoptotic pathway is associated with human cancer development

    BAD-mediated apoptotic pathway is associated with human cancer development by Xiaomang B. Stickles, Douglas C. Marchion, Elona Biçaku, E. Al Sawah, Forough Abbasi, Yin Xiong, Nadim Bou Zgheib, Bernadette M. Boac, Brian C. Orr, Patricia L. Judson, Amy Berry, Ardeshir Hakam, Robert M. Wenham, Sachin M. Apte, Anders Berglund, Johnathan M. Lancaster

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours

    A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibit... by Irene Braña, Raanan Berger, Talia Golan, Paul Haluska, Jeff Edenfield, J. Fiorica, John Stephenson, Lainie P. Martin, S.N. Westin, P. Hanjani, Mary Jones, Khaldoun Almhanna, Robert M. Wenham, Daniel M. Sullivan, W. S. Dalton, Alexandra Gunchenko, J. Cheng, Lillian L. Siu, Jhanelle E. Gray

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive <i>TP53</i>-mutant Ovarian Cancer

    A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive <i>TP53</i>-mutant Ovarian Cancer by Amit M. Oza, Maria Del Pilar Estevez-Diz, Eva‐Maria Grischke, Marcia Hall, Frederik Marmé, Diane Provencher, Denise Uyar, Johanne I. Weberpals, Robert M. Wenham, Naomi Laing, Michaël Tracy, Tomoko Freshwater, Mark A. Lee, Liu Ji, Jingjun Qiu, Shelonitda Rose, Eric H. Rubin, Kathleen N. Moore

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Olfactory Receptor OR2H1 Is an Effective Target for CAR T Cells in Human Epithelial Tumors

    Olfactory Receptor OR2H1 Is an Effective Target for CAR T Cells in Human Epithelial Tumors by Alexandra Martin, Carmen M. Anadon, Subir Biswas, Jessica A. Mine, Katelyn F. Handley, Kyle K. Payne, Gunjan Mandal, Ricardo A. Chaurio, John J. Powers, Kimberly B. Sprenger, Kristen E. Rigolizzo, Patrick Innamarato, Carly M. Harro, Sumit Mehta, Bradford A. Perez, Robert M. Wenham, José R. Conejo-García

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Supplementary material and tables from A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive &lt;i&gt;TP53&lt;/i&gt;-mutant Ovarian Cancer

    Supplementary material and tables from A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive &l... by Amit M. Oza, Maria Del Pilar Estevez-Diz, Eva‐Maria Grischke, Marcia Hall, Frederik Marmé, Diane Provencher, Denise Uyar, Johanne I. Weberpals, Robert M. Wenham, Naomi Laing, Michaël Tracy, Tomoko Freshwater, Mark A. Lee, Liu Ji, Jingjun Qiu, Shelonitda Rose, Eric H. Rubin, Kathleen N. Moore

    Published 2023
    Get full text Get full text
    Pré-impressão
    Save to List
    Saved in:
  19. 19
    Supplementary material and tables from A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive &lt;i&gt;TP53&lt;/i&gt;-mutant Ovarian Cancer

    Supplementary material and tables from A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive &l... by Amit M. Oza, Maria Del Pilar Estevez-Diz, Eva‐Maria Grischke, Marcia Hall, Frederik Marmé, Diane Provencher, Denise Uyar, Johanne I. Weberpals, Robert M. Wenham, Naomi Laing, Michaël Tracy, Tomoko Freshwater, Mark A. Lee, Liu Ji, Jingjun Qiu, Shelonitda Rose, Eric H. Rubin, Kathleen N. Moore

    Published 2023
    Get full text Get full text
    Pré-impressão
    Save to List
    Saved in:
  20. 20
    Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial

    Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial by Michel Fabbro, Kathleen N. Moore, Anne Dørum, Anna V. Tinker, Sven Mahner, Isabel Bover, Susana Banerjee, Germana Tognon, Frédéric Goffin, Ronnie Shapira‐Frommer, Robert M. Wenham, Kristina Hellman, Diane Provencher, Philipp Harter, Isabel Palacio Vázquez, Philippe Follana, Mario Javier Pineda, Mansoor Raza Mirza, Sebastien Hazard, Ursula A. Matulonis

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: